Home » Archive

Xconomy

News, Syndication, Xconomy »

San Diego Life Sciences Roundup: Receptos, Auspex, Avelas, and More

Posted by sandiegobiotech January 10th, 2014 .
No Comments

Amid the flurry of announcements leading up to next week’s JP Morgan Healthcare Conference in San Francisco, you might have missed some significant funding deals coming out of San Diego’s life…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

U.S. Biomedical Research at a Precipice

Posted by sandiegobiotech January 9th, 2014 .
No Comments

[Editor's Note: this post was co-authored by Justin Chakma, Dr. Reshma Jagsi, and Stephen M. Sammut.] Since 1950, U.S. government funding has supported research underlying 84 percent of Nobel Prizes…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

Josh Boger Finds Beauty Off the Coast of Fiji, in Life After Vertex

Posted by sandiegobiotech January 6th, 2014 .
No Comments

What has Josh Boger been doing the past four years in his supposed “retirement” from Vertex Pharmaceuticals? Turns out, he’s found peace and beauty. He discovered it about as far away from the…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

Scientific Reproducibility: Raising the Standards for Biomedicine

Posted by sandiegobiotech January 3rd, 2014 .
No Comments

The vast majority of findings published in high-profile biomedical research publications can’t be reproduced by independent laboratories. Multiple groups have come to this same shocking conclusion in…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

My Top Picks in Bio-Venture Innovations, and Predictions for 2014

Posted by sandiegobiotech December 26th, 2013 .
No Comments

I am a biotech VC, but not a techie. So I don’t follow stem cells, gene therapy, and other similar “blockbuster” technologies in the life sciences. Rather than looking at all the gosh-and-golly stuff…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

We Ask the Xconomists: Some Quick Predictions for the New Year

Posted by sandiegobiotech December 25th, 2013 .
No Comments

As 2013 drew to a close, we asked some of our Xconomists to ponder innovation, past and future, and to give us their predictions for the breakout innovations they expect to see in their respective…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

Observations From Korea’s Creative Economy 2013 Conference

Posted by sandiegobiotech December 24th, 2013 .
No Comments

Innovation is one of those goals that transcends borders. Spurring technology innovation, and through it the creation of new industries that accelerate job growth, is always high on the agenda of any…

[[Click headline to continue reading.]]

More...

Diagnostics, News, Syndication, Xconomy »

10 Tips for Maximizing the JP Morgan Healthcare Experience

Posted by sandiegobiotech December 23rd, 2013 .
No Comments

San Francisco, we’re coming. Of course, you are ready for the biotech onslaught. The cab drivers, hotel people, cops, security dudes, restaurant and bar staff—you all know the drill come…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

For CytRx’s Insiders, What a Difference a Day Makes

Posted by sandiegobiotech December 17th, 2013 .
No Comments

CytRx (NASDAQ: CYTR) investors had a lot to be happy about last week.  The good times came on Wednesday, Dec. 11, after the small cap biotech announced encouraging summary results from a mid-stage…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

Cubist Shares Climb As Antibiotic Scores in Phase 3 Again

Posted by sandiegobiotech December 16th, 2013 .
No Comments

Cubist Pharmaceuticals (NASDAQ: CBST) just got some more promising results to take to regulators next year. The Lexington, MA-based company said today that CXA-201— the antibiotic it acquired…

[[Click headline to continue reading.]]

More...